Categories: Research

Published results of drug trials sponsored by the pharmaceutical industry are more likely than trials not sponsored by the industry to favor drug over placebo, according to

Mass spectrometry technology and techniques are key to knowing the structure and function of proteins and how they act in the constantly moving highways of biological systems.

The odds of finding a chemical compound that can be developed into a drug are not good, says Thomas James, PhD, chair of the UCSF School of Pharmacy's department of pharmaceutical chemistry, but those odds can be improved by university scientists.

The Strategic Opportunities Support Center (SOS Center) at UCSF is accepting inaugural proposals for projects that will carry forward the translation of research studies into clinical and human studies and eventually into community practice.

A new California law, effective January 5, 2007, is designed to give pharmacists more time to work directly with patients to ensure greater medication safety by allowing specially trained technicians to assume time-consuming tasks of filling and checking prescriptions. Research led by the UCSF...

The UCSF School of Pharmacy has received a US$3.7 million grant from the Amgen Foundation to train student pharmacists in all 7 California schools of pharmacy with the skills they need to help the underserved elderly make the best Medicare Part D choices.

By understanding the complicated systems that make up biology, we will understand more about the individual parts, how they work together, communicate, and mobilize into action, according to Chao Tang, PhD, UCSF School of Pharmacy faculty member.

UCSF School of Pharmacy faculty member James Wells, PhD, director of the Small Molecule Discovery Center, describes his approach, which uses precise, sophisticated matchmaking techniques, to improving the success rate of finding chemical comp

Science could benefit from funding for deep innovation and time to dream, says Ken Dill, PhD, UCSF School of Pharmacy faculty member and associate dean of research.

Today’s science lacks funding for truly deep innovation, says Ken Dill, PhD, UCSF School of Pharmacy faculty member and associate dean of research.

Full story

Science Cafe, Bring Back the Ivory Tower, Part 1 of 2